NILOTINIB

Categories
Therapeutic
Curator
Karen Rothfels
Designer
Cristoffer Sevilla
Description
Nilotinib is a Type-2 kinase inhibitor and was first approved by the FDA in 2007.
Icon preview
Icon NILOTINIB
SVG
PNG
EMF
Locations in the PathwayBrowser
Expand all
Entries for NILOTINIB
nilotinib [cytosol]
PYY(29-64) [extracellular region]
External References
IUPHAR
Cite Us!